Pearl IRB was featured in the August 21st weekly print publication and on the web. See below for an excerpt:
“Before the first volunteer takes a needle in the arm to test an experimental drug, the proposed clinical trial must first be vetted by a panel of experts, known as an institutional review board, or IRB. Health.
In Indiana, the IRB typically is the province of medical experts at a hospital or university. But recently, two former Eli Lilly and Co. employees launched the state’s first commercial IRB, saying Pearl IRB could help attract and support more clinical trials here.
That’s been a goal of industry groups such as the Indiana Health Industry Forum’s clinical trial task force, which is trying to stoke clinical trial activity and capabilities to support and grow the life sciences and medical device industry.
Indiana lags some neighboring states in clinical trials, with 4,556 in process or completed over the last several years, compared with 7,737 in Illinois and 8,206 in Ohio, according to the National Institutes of Health.”
To view full article, click here.